Abstract
Behçet’s disease (BD) is a rare, multisystemic, chronic vasculitic disorder with unknown etiology. Intracardiac thrombus formation and pulmonary artery aneurysm in BD are very rare. The treatment protocol in patients with vascular involvement, particularly those with pulmonary artery aneurysm accompanied by thrombosis, have not been clearly defined. In this article, we report an exceptional case, who had been treated unsuccessfully with a combination of anti-inflammatory/immunosuppressive therapy and thrombolytic agents, to discuss the poor prognosis of pulmonary artery aneurysm accompanying intracardiac thrombosis in juvenile BD.
Similar Articles
Article Info
Published In
Journal
Archives of Rheumatology
Volume / Issue
Volume 34 · Issue 4 · December 2019
Pages
451-456
History
Published Online
December 31, 2019
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Affiliations
1
Nükhet ALADAĞ ÇİFTDEMİR
Department of Pediatrics, Trakya University Faculty of Medicine, Edirne, Turkey
2
Selman GÖKALP
Department of Pediatrics, Cerrahpaşa University Faculty of Medicine, Istanbul, Turkey
3
Tuba EREN
Department of Pediatrics, Trakya University Faculty of Medicine, Edirne, Turkey
Cite this Article
Nükhet ALADAĞ ÇİFTDEMİR, Selman GÖKALP, & Tuba EREN. (2019). Is Immunosuppressive and Thrombolytic Therapy Really Effective in a Patient With Intracardiac Thrombosis and Pulmonary Artery Aneurysm due to Behçet’s Disease?. Archives of Rheumatology, 34(4), 451–456. https://doi.org/10.5606/ArchRheumatol.2019.7169
Outlines